Outcomes of Oral Metronomic Therapy in Patients with Lymphomas View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-01

AUTHORS

Sharada Mailankody, Prasanth Ganesan, Archit Joshi, Trivadi S. Ganesan, Venkatraman Radhakrishnan, Manikandan Dhanushkodi, Nikita Mehra, Jayachandran Perumal Kalaiyarasi, Krishnarathinam Kannan, Tenali Gnana Sagar

ABSTRACT

Oral Metronomic chemotherapy (OMC) is used in patients with lymphoma who may not tolerate intravenous chemotherapy or have refractory disease. It is cheaper, less toxic and easy to administer. Adult patients with lymphoma who received OMC (combination of cyclophosphamide, etoposide and prednisolone) were included in this retrospective analysis. Response assessment was clinical with limited use of radiology. Progression free and overall survival (PFS and OS) were calculated from the time of start of OMC until documentation of disease progression or death. Between 2007 and 2017, 149 patients were given OMC [median age: 62 years (19-87); 94 patients (63.1%) male]. Majority [112 patients (75.2%)] had stage III/IV disease. The most common subtype of lymphoma was diffuse large B cell lymphoma (40.9%). OMC was used at diagnosis in 41 patients (27.5%) and after relapse in 108 patients (72.5%). Overall response rates were 43.9 and 41.7% with clinical CR in 14 (34.1%) and 21 (19.4%) in patients given first line and later lines of OMC respectively. After a median follow up of 12 months (range 1-123 months), median PFS and OS were 10.5 (95% CI 8.6-12.5) and 18.8 (95% CI 12.1-25.5) months respectively. PFS and OS at 12 months were 47.6 and 64.2% respectively. Though OMC is used in many centers in India, there is scanty published information on its efficacy in lymphoma. In this analysis, we demonstrate its activity in a subset of patients with predominantly high-grade and advanced stage NHL. OMC is a useful option in frail patients and a small proportion can achieve deep and long lasting responses. More... »

PAGES

50-56

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s12288-018-0995-0

DOI

http://dx.doi.org/10.1007/s12288-018-0995-0

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1105966778

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30828148


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mailankody", 
        "givenName": "Sharada", 
        "id": "sg:person.01150103765.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150103765.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganesan", 
        "givenName": "Prasanth", 
        "id": "sg:person.0716343050.48", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716343050.48"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Joshi", 
        "givenName": "Archit", 
        "id": "sg:person.012520032640.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012520032640.78"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ganesan", 
        "givenName": "Trivadi S.", 
        "id": "sg:person.01354150255.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Radhakrishnan", 
        "givenName": "Venkatraman", 
        "id": "sg:person.010316745623.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010316745623.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dhanushkodi", 
        "givenName": "Manikandan", 
        "id": "sg:person.01225301441.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225301441.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Mehra", 
        "givenName": "Nikita", 
        "id": "sg:person.013004716016.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013004716016.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kalaiyarasi", 
        "givenName": "Jayachandran Perumal", 
        "id": "sg:person.011770565440.24", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011770565440.24"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kannan", 
        "givenName": "Krishnarathinam", 
        "id": "sg:person.0657501276.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657501276.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Cancer Institute", 
          "id": "https://www.grid.ac/institutes/grid.418600.b", 
          "name": [
            "Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Sagar", 
        "givenName": "Tenali Gnana", 
        "id": "sg:person.015576370407.55", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015576370407.55"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/s1470-2045(13)70056-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007730010"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2011.06.040", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009894068"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1158/1078-0432.ccr-06-0474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011109711"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdf093", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011228612"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1593/neo.131910", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012900683"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31820dbf56", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015202756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/coc.0b013e31820dbf56", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015202756"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3136-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015326668", 
          "https://doi.org/10.1007/s00280-016-3136-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00280-016-3136-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015326668", 
          "https://doi.org/10.1007/s00280-016-3136-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1172/jci9872", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018143975"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4103/2278-330x.181623", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022481476"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/bjh.13480", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022747908"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ejca.2010.11.025", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024513881"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.23422", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024988287"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030178153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/cncr.25055", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030178153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.urology.2011.08.010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043606526"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1074623639", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-01", 
    "datePublishedReg": "2019-01-01", 
    "description": "Oral Metronomic chemotherapy (OMC) is used in patients with lymphoma who may not tolerate intravenous chemotherapy or have refractory disease. It is cheaper, less toxic and easy to administer. Adult patients with lymphoma who received OMC (combination of cyclophosphamide, etoposide and prednisolone) were included in this retrospective analysis. Response assessment was clinical with limited use of radiology. Progression free and overall survival (PFS and OS) were calculated from the time of start of OMC until documentation of disease progression or death. Between 2007 and 2017, 149 patients were given OMC [median age: 62\u00a0years (19-87); 94 patients (63.1%) male]. Majority [112 patients (75.2%)] had stage III/IV disease. The most common subtype of lymphoma was diffuse large B cell lymphoma (40.9%). OMC was used at diagnosis in 41 patients (27.5%) and after relapse in 108 patients (72.5%). Overall response rates were 43.9 and 41.7% with clinical CR in 14 (34.1%) and 21 (19.4%) in\u00a0patients given first line and later lines of OMC respectively. After a median follow up of 12\u00a0months (range 1-123\u00a0months), median PFS and OS were 10.5 (95% CI 8.6-12.5) and 18.8 (95% CI 12.1-25.5) months respectively. PFS and OS at 12\u00a0months were 47.6 and 64.2% respectively. Though OMC is used in many centers in India, there is scanty published information on its efficacy in lymphoma. In this analysis, we demonstrate its activity in a subset of patients with predominantly high-grade and advanced stage NHL. OMC is a useful option in frail patients and a small proportion can achieve deep and long lasting\u00a0responses.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s12288-018-0995-0", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1107805", 
        "issn": [
          "0971-4502", 
          "0974-0449"
        ], 
        "name": "Indian Journal of Hematology and Blood Transfusion", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "35"
      }
    ], 
    "name": "Outcomes of Oral Metronomic Therapy in Patients with Lymphomas", 
    "pagination": "50-56", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "661ddcbe48bfab6097fa704ea64bbdc98d49c6dff8f15cd44716983ea1ccacf3"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30828148"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "9425818"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s12288-018-0995-0"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1105966778"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s12288-018-0995-0", 
      "https://app.dimensions.ai/details/publication/pub.1105966778"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000352_0000000352/records_60351_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs12288-018-0995-0"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-0995-0'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-0995-0'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-0995-0'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s12288-018-0995-0'


 

This table displays all metadata directly associated to this object as RDF triples.

177 TRIPLES      21 PREDICATES      44 URIs      21 LITERALS      9 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s12288-018-0995-0 schema:about anzsrc-for:11
2 anzsrc-for:1112
3 schema:author Naf3acd9f5fff4effad5313e5852b9be1
4 schema:citation sg:pub.10.1007/s00280-016-3136-1
5 https://app.dimensions.ai/details/publication/pub.1074623639
6 https://doi.org/10.1002/cncr.23422
7 https://doi.org/10.1002/cncr.25055
8 https://doi.org/10.1016/j.ejca.2010.11.025
9 https://doi.org/10.1016/j.ejca.2011.06.040
10 https://doi.org/10.1016/j.urology.2011.08.010
11 https://doi.org/10.1016/s1470-2045(13)70056-1
12 https://doi.org/10.1093/annonc/mdf093
13 https://doi.org/10.1097/coc.0b013e31820dbf56
14 https://doi.org/10.1111/bjh.13480
15 https://doi.org/10.1158/1078-0432.ccr-06-0474
16 https://doi.org/10.1172/jci9872
17 https://doi.org/10.1593/neo.131910
18 https://doi.org/10.4103/2278-330x.181623
19 schema:datePublished 2019-01
20 schema:datePublishedReg 2019-01-01
21 schema:description Oral Metronomic chemotherapy (OMC) is used in patients with lymphoma who may not tolerate intravenous chemotherapy or have refractory disease. It is cheaper, less toxic and easy to administer. Adult patients with lymphoma who received OMC (combination of cyclophosphamide, etoposide and prednisolone) were included in this retrospective analysis. Response assessment was clinical with limited use of radiology. Progression free and overall survival (PFS and OS) were calculated from the time of start of OMC until documentation of disease progression or death. Between 2007 and 2017, 149 patients were given OMC [median age: 62 years (19-87); 94 patients (63.1%) male]. Majority [112 patients (75.2%)] had stage III/IV disease. The most common subtype of lymphoma was diffuse large B cell lymphoma (40.9%). OMC was used at diagnosis in 41 patients (27.5%) and after relapse in 108 patients (72.5%). Overall response rates were 43.9 and 41.7% with clinical CR in 14 (34.1%) and 21 (19.4%) in patients given first line and later lines of OMC respectively. After a median follow up of 12 months (range 1-123 months), median PFS and OS were 10.5 (95% CI 8.6-12.5) and 18.8 (95% CI 12.1-25.5) months respectively. PFS and OS at 12 months were 47.6 and 64.2% respectively. Though OMC is used in many centers in India, there is scanty published information on its efficacy in lymphoma. In this analysis, we demonstrate its activity in a subset of patients with predominantly high-grade and advanced stage NHL. OMC is a useful option in frail patients and a small proportion can achieve deep and long lasting responses.
22 schema:genre research_article
23 schema:inLanguage en
24 schema:isAccessibleForFree false
25 schema:isPartOf N7a0ec1c600d44958ab91319ff9ee910b
26 Na64dd5e006d8498ba7cd2545340bc9cf
27 sg:journal.1107805
28 schema:name Outcomes of Oral Metronomic Therapy in Patients with Lymphomas
29 schema:pagination 50-56
30 schema:productId N42ff57b593ce4601b93142f5a8bc29ee
31 Na3b5f234a3744eacb3bba1285ea3b5e3
32 Nb2f386f7cc3c4541a282ffa010de61d1
33 Nb52217a47e0e42189abda488cd4b7bff
34 Ndfbcbfdde2064a2aaf386b01ba98d94f
35 schema:sameAs https://app.dimensions.ai/details/publication/pub.1105966778
36 https://doi.org/10.1007/s12288-018-0995-0
37 schema:sdDatePublished 2019-04-11T11:02
38 schema:sdLicense https://scigraph.springernature.com/explorer/license/
39 schema:sdPublisher N599513133b894523bb7a9fc596debe06
40 schema:url https://link.springer.com/10.1007%2Fs12288-018-0995-0
41 sgo:license sg:explorer/license/
42 sgo:sdDataset articles
43 rdf:type schema:ScholarlyArticle
44 N1cad4b3fc81a4c97937f7481c3e96d6a rdf:first sg:person.015576370407.55
45 rdf:rest rdf:nil
46 N3258e2091e0f47bc95461b9ebbb2e5d9 rdf:first sg:person.01354150255.82
47 rdf:rest Ne0ec0235b0bd4f1b88de616c473216c4
48 N42ff57b593ce4601b93142f5a8bc29ee schema:name dimensions_id
49 schema:value pub.1105966778
50 rdf:type schema:PropertyValue
51 N463d918d05ef4d6aacc4faa2b868fdd6 rdf:first sg:person.012520032640.78
52 rdf:rest N3258e2091e0f47bc95461b9ebbb2e5d9
53 N4756eaa7f7904abdaa9f24dd097a375b rdf:first sg:person.013004716016.82
54 rdf:rest N79a9deeea7fc45b2a7a3d5fdba33fc93
55 N4eb1957357214b01a182b29f0bb51728 rdf:first sg:person.01225301441.63
56 rdf:rest N4756eaa7f7904abdaa9f24dd097a375b
57 N599513133b894523bb7a9fc596debe06 schema:name Springer Nature - SN SciGraph project
58 rdf:type schema:Organization
59 N79a9deeea7fc45b2a7a3d5fdba33fc93 rdf:first sg:person.011770565440.24
60 rdf:rest N8c038059e4bb43c18900e386012cada7
61 N7a0ec1c600d44958ab91319ff9ee910b schema:volumeNumber 35
62 rdf:type schema:PublicationVolume
63 N8c038059e4bb43c18900e386012cada7 rdf:first sg:person.0657501276.96
64 rdf:rest N1cad4b3fc81a4c97937f7481c3e96d6a
65 Na3b5f234a3744eacb3bba1285ea3b5e3 schema:name doi
66 schema:value 10.1007/s12288-018-0995-0
67 rdf:type schema:PropertyValue
68 Na64dd5e006d8498ba7cd2545340bc9cf schema:issueNumber 1
69 rdf:type schema:PublicationIssue
70 Naf3acd9f5fff4effad5313e5852b9be1 rdf:first sg:person.01150103765.96
71 rdf:rest Nff572701a4144de3bcce7a696b852863
72 Nb2f386f7cc3c4541a282ffa010de61d1 schema:name nlm_unique_id
73 schema:value 9425818
74 rdf:type schema:PropertyValue
75 Nb52217a47e0e42189abda488cd4b7bff schema:name readcube_id
76 schema:value 661ddcbe48bfab6097fa704ea64bbdc98d49c6dff8f15cd44716983ea1ccacf3
77 rdf:type schema:PropertyValue
78 Ndfbcbfdde2064a2aaf386b01ba98d94f schema:name pubmed_id
79 schema:value 30828148
80 rdf:type schema:PropertyValue
81 Ne0ec0235b0bd4f1b88de616c473216c4 rdf:first sg:person.010316745623.36
82 rdf:rest N4eb1957357214b01a182b29f0bb51728
83 Nff572701a4144de3bcce7a696b852863 rdf:first sg:person.0716343050.48
84 rdf:rest N463d918d05ef4d6aacc4faa2b868fdd6
85 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
86 schema:name Medical and Health Sciences
87 rdf:type schema:DefinedTerm
88 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
89 schema:name Oncology and Carcinogenesis
90 rdf:type schema:DefinedTerm
91 sg:journal.1107805 schema:issn 0971-4502
92 0974-0449
93 schema:name Indian Journal of Hematology and Blood Transfusion
94 rdf:type schema:Periodical
95 sg:person.010316745623.36 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
96 schema:familyName Radhakrishnan
97 schema:givenName Venkatraman
98 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010316745623.36
99 rdf:type schema:Person
100 sg:person.01150103765.96 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
101 schema:familyName Mailankody
102 schema:givenName Sharada
103 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150103765.96
104 rdf:type schema:Person
105 sg:person.011770565440.24 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
106 schema:familyName Kalaiyarasi
107 schema:givenName Jayachandran Perumal
108 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.011770565440.24
109 rdf:type schema:Person
110 sg:person.01225301441.63 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
111 schema:familyName Dhanushkodi
112 schema:givenName Manikandan
113 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225301441.63
114 rdf:type schema:Person
115 sg:person.012520032640.78 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
116 schema:familyName Joshi
117 schema:givenName Archit
118 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012520032640.78
119 rdf:type schema:Person
120 sg:person.013004716016.82 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
121 schema:familyName Mehra
122 schema:givenName Nikita
123 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.013004716016.82
124 rdf:type schema:Person
125 sg:person.01354150255.82 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
126 schema:familyName Ganesan
127 schema:givenName Trivadi S.
128 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01354150255.82
129 rdf:type schema:Person
130 sg:person.015576370407.55 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
131 schema:familyName Sagar
132 schema:givenName Tenali Gnana
133 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015576370407.55
134 rdf:type schema:Person
135 sg:person.0657501276.96 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
136 schema:familyName Kannan
137 schema:givenName Krishnarathinam
138 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0657501276.96
139 rdf:type schema:Person
140 sg:person.0716343050.48 schema:affiliation https://www.grid.ac/institutes/grid.418600.b
141 schema:familyName Ganesan
142 schema:givenName Prasanth
143 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0716343050.48
144 rdf:type schema:Person
145 sg:pub.10.1007/s00280-016-3136-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015326668
146 https://doi.org/10.1007/s00280-016-3136-1
147 rdf:type schema:CreativeWork
148 https://app.dimensions.ai/details/publication/pub.1074623639 schema:CreativeWork
149 https://doi.org/10.1002/cncr.23422 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024988287
150 rdf:type schema:CreativeWork
151 https://doi.org/10.1002/cncr.25055 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030178153
152 rdf:type schema:CreativeWork
153 https://doi.org/10.1016/j.ejca.2010.11.025 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024513881
154 rdf:type schema:CreativeWork
155 https://doi.org/10.1016/j.ejca.2011.06.040 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009894068
156 rdf:type schema:CreativeWork
157 https://doi.org/10.1016/j.urology.2011.08.010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043606526
158 rdf:type schema:CreativeWork
159 https://doi.org/10.1016/s1470-2045(13)70056-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007730010
160 rdf:type schema:CreativeWork
161 https://doi.org/10.1093/annonc/mdf093 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011228612
162 rdf:type schema:CreativeWork
163 https://doi.org/10.1097/coc.0b013e31820dbf56 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015202756
164 rdf:type schema:CreativeWork
165 https://doi.org/10.1111/bjh.13480 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022747908
166 rdf:type schema:CreativeWork
167 https://doi.org/10.1158/1078-0432.ccr-06-0474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011109711
168 rdf:type schema:CreativeWork
169 https://doi.org/10.1172/jci9872 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018143975
170 rdf:type schema:CreativeWork
171 https://doi.org/10.1593/neo.131910 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012900683
172 rdf:type schema:CreativeWork
173 https://doi.org/10.4103/2278-330x.181623 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022481476
174 rdf:type schema:CreativeWork
175 https://www.grid.ac/institutes/grid.418600.b schema:alternateName Cancer Institute
176 schema:name Department of Medical Oncology, Cancer Institute (WIA), Sardar Patel Road, Adyar, 600020, Chennai, Tamil Nadu, India
177 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...